| Literature DB >> 7989401 |
J Y Legendre1, S Cote, D Pradeau, M Hamon, C Vitzling, D Lavene, A Tarral.
Abstract
Although renal-failure-related hyperphosphataemia can be corrected by various phosphate binders, there remains a need for safer and more efficient formulations to precipitate phosphate. This work describes both a theoretical approach and a phosphate precipitation test in order to design efficient binding calcium salts formulations. The results show that the combination of a soluble calcium salt (the gluconolactate) and a proton-consuming calcium salt (the carbonate) can precipitate phosphate effectively. Furthermore, the theoretical computations correlate well with the ability of the salt to bind phosphate in vitro.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7989401 DOI: 10.1111/j.1365-2710.1994.tb00679.x
Source DB: PubMed Journal: J Clin Pharm Ther ISSN: 0269-4727 Impact factor: 2.512